Nystatin A3
Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.
Cross Reference
Introduction
To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Nystatin A3?
Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Nystatin A3
PubChem Associated disorders and diseases
What pathways are associated with Nystatin A3
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Nystatin A3?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
What functions are associated with Nystatin A3?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Nystatin A3?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
What genes are associated with Nystatin A3?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Nystatin A3?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Nystatin A3
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Kantarcioglu AS et al. | Microbiota-Gut-Brain Axis: Yeast Species Isolated from Stool Samples of Children with Suspected or Diagnosed Autism Spectrum Disorders and In Vitro Susceptibility Against Nystatin and Fluconazole. | 2016 | Mycopathologia | pmid:26442855 |
| Russo A et al. | Role of oral nystatin prophylaxis in cardiac surgery with prolongedextracorporeal circulation. | 2017 | Mycoses | pmid:28877374 |
| Ozturk MA et al. | Oral nystatin prophylaxis to prevent invasive candidiasis in Neonatal Intensive Care Unit. | 2006 | Mycoses | pmid:17022766 |
| Abu-Elteen KH | Incidence and distribution of Candida species isolated from human skin in Jordan. | 1999 | Mycoses | pmid:10424102 |
| Messier C and Grenier D | Effect of licorice compounds licochalcone A, glabridin and glycyrrhizic acid on growth and virulence properties of Candida albicans. | 2011 | Mycoses | pmid:21615543 |
| Mousa HA and al-Bader SM | Yeast infection of burns. | 2001 | Mycoses | pmid:11486451 |
| Blaschke-Hellmessen R and Schwarze U | Bioassay for determination of nystatin in faeces after oral application. | 1990 | Mycoses | pmid:2113608 |
| Fan SR and Liu XP | In vitro fluconazole and nystatin susceptibility and clinical outcome in complicated vulvovaginal candidosis. | 2011 | Mycoses | pmid:20406393 |
| Müller J | [Electron microscopy of Candida albicans]. | 1999 | Mycoses | pmid:10592709 |
| Monteiro DR et al. | Antifungal activity of silver nanoparticles in combination with nystatin and chlorhexidine digluconate against Candida albicans and Candida glabrata biofilms. | 2013 | Mycoses | pmid:23773119 |
| Ellepola AN et al. | The postantifungal effect of nystatin and its impact on adhesion attributes of oral Candida dubliniensis isolates. | 2014 | Mycoses | pmid:23773155 |
| Hoppe JE et al. | Orointestinal yeast colonization of paediatric oncologic patients during antifungal prophylaxis: results of quantitative culture and Candida serology and comparison of three polyenes. | 1995 Jan-Feb | Mycoses | pmid:7637681 |
| Auger P et al. | Treatment of cutaneous candidosis in guinea pigs: effect of zinc oxide on the antifungal efficacy of nystatin. | 1989 | Mycoses | pmid:2608092 |
| Li D et al. | Efficacy and safety of probiotics in the treatment of Candida-associated stomatitis. | 2014 | Mycoses | pmid:23952962 |
| Ohnemus U et al. | An ex-vivo oral mucosa infection model for the evaluation of the topical activity of antifungal agents. | 2008 | Mycoses | pmid:18076591 |
| Schäfer-Korting M et al. | Clinical use of oral nystatin in the prevention of systemic candidosis in patients at particular risk. | 1996 Sep-Oct | Mycoses | pmid:9009654 |
| Boon JM et al. | Comparison of ketoconazole suspension and nystatin in the treatment of newborns and infants with oral candidosis. | 1989 | Mycoses | pmid:2779612 |
| Broughton MC et al. | Polyene resistance in ergosterol producing strains of Candida albicans. | 1991 Jan-Feb | Mycoses | pmid:1922193 |
| Sharifzadeh A et al. | Evaluation of virulence factors and antifungal susceptibility patterns of different Candida species isolated from the female camel (Camelus dromedarius) genital tract. | 2015 | Mycoses | pmid:26152466 |
| Preney L et al. | Experimental evaluation of antifungal and antiseptic agents against Rhodotorula spp. | 2003 | Mycoses | pmid:14641623 |